Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, how many people historically registered with (a) MFET Ltd. and (b) the Skipton Fund have been (i) non-hemophiliacs infected following NHS treatment with whole blood transfusions and (ii) haemophiliacs infected following NHS treatment with blood concentrate or cryoprecipitate.

Of the 395 people who have registered with MFET Ltd since its inception:

(i) 15 are individuals without bleeding disorders who were infected though treatment with NHS-supplied blood or blood products; and

(ii) 338 are individuals with bleeding disorders who were infected through treatment with NHS-supplied blood products, such as factor concentrates and cryoprecipitate.

The remaining 42 individuals are people who were infected with HIV by their partner who was infected by treatment with NHS blood or blood products.

Of the 5,181 people who have registered with the Skipton Fund and received a Stage 1 payment as at 30 September 2014:

(i) 2,519 are individuals without a bleeding disorder, who were infected though treatment with NHS-supplied blood or blood products; and

(ii) 2,662 are individuals with a bleeding disorder, who were infected though treatment with NHS-supplied blood or blood products, such as factor concentrates and cryoprecipitate.